Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 601-612 of 2,301
Drug study icon
CompletedNCT03869736

Nitrous Oxide for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States, Australia
Sponsor
Bayside Health
Condition
Depression
Drug study icon
CompletedNCT06235905

Of SPN-820 in Adults With Major Depressive Disorder

This study is completed in the United States. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Navitor Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT04116528

Opiate Suicide Study in people with Major Depression

This study is comparing Ketamine with placebo for people with depression. Participants receive Ketamine or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression
Drug study icon
Active Not RecruitingNCT03554174

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

This study is comparing Low Dose Psilocybin with placebo for people with depression. Participants receive Low Dose Psilocybin or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Depression
Drug study icon
CompletedNCT05399498

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

This study exists to understand whether psilocybin treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to psilocybin treatment in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Chicago
Condition
Depression
Drug study icon
Active Not RecruitingNCT04620759

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Addiction

This study is comparing Psilocybin with placebo for people with depression or Addiction. Participants receive Psilocybin or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression, Addiction
Drug study icon
CompletedNCT04855760

Safety of REL-1017 for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Relmada Therapeutics, Inc.
Condition
Depression
Device study icon
CompletedNCT03433339

Spinal Cord Stimulation for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Depression
Drug study icon
TerminatedNCT04722666

MIJ821 for depression

This study was terminated in the United States, in Canada, in Argentina, .... It is testing MIJ821 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Argentina, ...
Sponsor
Novartis Pharmaceuticals
Condition
Depression, Suicidality
Drug study icon
CompletedNCT06058039

Effects of Oral NMRA-335140 in people with Major Depressive Disorder

This study is completed in the United States, in France, in Bulgaria, .... It is testing Effects of Oral NMRA-335140 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.